Janux Therapeutics OverviewJanux Therapeutics Other Income Expense Net
Other Income/Expense Net for JANX.
Quarterly Other Income/Expense
$9.85M
↓ 13.5% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$1.54M
↓ 104.29% YoY
Trailing 12 months ending Mar 31, 2026